🍽️ pravastatin,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Hypercholesterolemia: Pravastatin is indicated for the treatment of primary hypercholesterolemia (elevated levels of cholesterol in the blood) and mixed dyslipidemia (elevated levels of both cholesterol and triglycerides). It works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis in the liver. By reducing the production of cholesterol, pravastatin helps lower LDL cholesterol (often referred to as "bad" cholesterol) and total cholesterol levels in the blood.

  2. Prevention of Cardiovascular Events: Pravastatin is used as an adjunct to dietary therapy to reduce the risk of cardiovascular events in individuals with established coronary heart disease, including those who have had a heart attack or unstable angina, and those with a history of coronary revascularization procedures such as angioplasty or coronary artery bypass grafting (CABG). By lowering cholesterol levels, pravastatin helps prevent the progression of atherosclerosis (build-up of plaque in the arteries) and reduces the risk of cardiovascular events such as heart attack, stroke, and transient ischemic attack (TIA).

  3. Prevention of Stroke: Pravastatin may be used to reduce the risk of stroke in individuals with a history of stroke or transient ischemic attack (TIA). By lowering cholesterol levels and stabilizing atherosclerotic plaques in the arteries supplying the brain, pravastatin helps reduce the risk of recurrent stroke.

  4. Peripheral Arterial Disease (PAD): Pravastatin is sometimes prescribed to individuals with peripheral arterial disease, a condition characterized by narrowing of the arteries in the legs and feet due to atherosclerosis. By improving blood flow to the lower extremities and reducing the risk of blood clots, pravastatin helps alleviate symptoms such as leg pain and cramping during physical activity.

  5. Diabetes: Pravastatin may be beneficial for individuals with diabetes, particularly those with dyslipidemia and other cardiovascular risk factors. By improving lipid profiles and reducing the risk of cardiovascular events, pravastatin contributes to the management of cardiovascular risk in diabetic patients.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of pravastatin,(prescription) On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces

Bacteria Impacted by pravastatin,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Escherichia genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Escherichia coli O25:H16 no rank Decreases 👶 Source Study
Escherichia coli O145:H34 no rank Decreases 👶 Source Study
Escherichia coli O16:H48 no rank Decreases 👶 Source Study
Escherichia coli O141:H4 no rank Decreases 👶 Source Study
Escherichia coli O139:H1 no rank Decreases 👶 Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Escherichia coli O158:H23 no rank Decreases 👶 Source Study
Escherichia coli O84:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H4 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O78:H51 no rank Decreases 👶 Source Study
Escherichia coli O18ac:H14 no rank Decreases 👶 Source Study
Escherichia coli O85:H1 no rank Decreases 👶 Source Study
Escherichia coli O7:H15 no rank Decreases 👶 Source Study
Escherichia coli O68:H12 no rank Decreases 👶 Source Study
Escherichia coli O55:H7 no rank Decreases 👶 Source Study
Escherichia coli O1:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O15:H12 no rank Decreases 👶 Source Study
Escherichia coli O170:H18 no rank Decreases 👶 Source Study
Escherichia coli O155:H21 no rank Decreases 👶 Source Study
Escherichia coli O19:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H5 no rank Decreases 👶 Source Study
Escherichia coli O20:H12 no rank Decreases 👶 Source Study
Escherichia coli O111 serogroup Decreases 👶 Source Study
Escherichia coli O121 serogroup Decreases 👶 Source Study
Escherichia coli O155 serogroup Decreases 👶 Source Study
Escherichia coli O177 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O3 serogroup Decreases 👶 Source Study
Escherichia coli O5 serogroup Decreases 👶 Source Study
Escherichia coli O86 serogroup Decreases 👶 Source Study
Escherichia coli O91 serogroup Decreases 👶 Source Study
Escherichia coli O103 serogroup Decreases 👶 Source Study
Escherichia coli O78 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O119 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O1:HNT serotype Decreases 👶 Source Study
Escherichia coli O10:K5(L):H4 serotype Decreases 👶 Source Study
Escherichia coli O103:H11 serotype Decreases 👶 Source Study
Escherichia coli O103:H25 serotype Decreases 👶 Source Study
Escherichia coli O104:H21 serotype Decreases 👶 Source Study
Escherichia coli O111:H11 serotype Decreases 👶 Source Study
Escherichia coli O111:H8 serotype Decreases 👶 Source Study
Escherichia coli O112ac:H19 serotype Decreases 👶 Source Study
Escherichia coli O114:H49 serotype Decreases 👶 Source Study
Escherichia coli O118:H16 serotype Decreases 👶 Source Study
Escherichia coli O121:H7 serotype Decreases 👶 Source Study
Escherichia coli O123:H11 serotype Decreases 👶 Source Study
Escherichia coli O127:H27 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O128:H2 serotype Decreases 👶 Source Study
Escherichia coli O128ac:H12 serotype Decreases 👶 Source Study
Escherichia coli O145:H25 serotype Decreases 👶 Source Study
Escherichia coli O145:NM serotype Decreases 👶 Source Study
Escherichia coli O146:H21 serotype Decreases 👶 Source Study
Escherichia coli O153:H2 serotype Decreases 👶 Source Study
Escherichia coli O156:H25 serotype Decreases 👶 Source Study
Escherichia coli O157:H43 serotype Decreases 👶 Source Study
Escherichia coli O157:NM serotype Decreases 👶 Source Study
Escherichia coli O165:H25 serotype Decreases 👶 Source Study
Escherichia coli O174:H2 serotype Decreases 👶 Source Study
Escherichia coli O174:H21 serotype Decreases 👶 Source Study
Escherichia coli O174:H8 serotype Decreases 👶 Source Study
Escherichia coli O176:H45 serotype Decreases 👶 Source Study
Escherichia coli O177:NM serotype Decreases 👶 Source Study
Escherichia coli O26:H1 serotype Decreases 👶 Source Study
Escherichia coli O28ac:NM serotype Decreases 👶 Source Study
Escherichia coli O29:H4 serotype Decreases 👶 Source Study
Escherichia coli O32:H37 serotype Decreases 👶 Source Study
Escherichia coli O6:H16:CFA/II serotype Decreases 👶 Source Study
Escherichia coli O69:H11 serotype Decreases 👶 Source Study
Escherichia coli O78:H12 serotype Decreases 👶 Source Study
Escherichia coli O79:H7 serotype Decreases 👶 Source Study
Escherichia coli O81:NM serotype Decreases 👶 Source Study
Escherichia coli O86:H34 serotype Decreases 👶 Source Study
Escherichia coli O91:H14 serotype Decreases 👶 Source Study
Escherichia coli O91:NM serotype Decreases 👶 Source Study
Escherichia coli ONT:H33 serotype Decreases 👶 Source Study
Escherichia coli O100:H21 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O16:H6 serotype Decreases 👶 Source Study
Escherichia coli O89m:H9 serotype Decreases 👶 Source Study
Escherichia coli O111:H- serotype Decreases 👶 Source Study
Escherichia coli O113:H21 serotype Decreases 👶 Source Study
Escherichia coli H20 serotype Decreases 👶 Source Study
Escherichia coli O150:H6 serotype Decreases 👶 Source Study
Escherichia coli O111:NM serotype Decreases 👶 Source Study
Escherichia coli O112ab:H8 serotype Decreases 👶 Source Study
Escherichia coli O99:H6 serotype Decreases 👶 Source Study
Escherichia coli O26:H11 serotype Decreases 👶 Source Study
Escherichia coli O145:H28 serotype Decreases 👶 Source Study
Escherichia coli O126:H45 serotype Decreases 👶 Source Study
Escherichia coli O2:H6 serotype Decreases 👶 Source Study
Escherichia coli O7:H4 serotype Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O25:NM serotype Decreases 👶 Source Study
Escherichia coli O25:H1 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Escherichia coli O125ac:K+:H10 serotype Decreases 👶 Source Study
Escherichia coli O6:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O152:H23 serotype Decreases 👶 Source Study
Escherichia coli O15:H18 serotype Decreases 👶 Source Study
Escherichia coli O39:NM serotype Decreases 👶 Source Study
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O2:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O8:H8 serotype Decreases 👶 Source Study
Escherichia coli O89m:H10 serotype Decreases 👶 Source Study
Escherichia coli O10:H32 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O157:H- serotype Decreases 👶 Source Study
Escherichia coli O45:H2 serotype Decreases 👶 Source Study
Escherichia coli O103:H2 serotype Decreases 👶 Source Study
Escherichia coli O167:H26 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O83:H1 serotype Decreases 👶 Source Study
Escherichia coli O9:H10 serotype Decreases 👶 Source Study
Escherichia coli O78:H4 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Agathobacter rectalis species Decreases 📓 Source Study

Impact of pravastatin,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.3 0.3
Allergic Rhinitis (Hay Fever) 0.6 0.2 2
Allergies 0.8 0.8
Allergy to milk products 0.2 0.6 -2
Alzheimer's disease 0.6 0.9 -0.5
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.6 0.2 2
Ankylosing spondylitis 0.8 0.8
Anorexia Nervosa 0.3 -0.3
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 0.2 0.2
Atherosclerosis 0.2 0.2
Atrial fibrillation 0.3 0.6 -1
Autism 0.6 0.8 -0.33
Autoimmune Disease 0.6 0.6
benign prostatic hyperplasia 0.6 0.6
Biofilm 0.2 0.2
Bipolar Disorder 0.6 0.6
Breast Cancer 0.2 0.2
Carcinoma 0.6 0.6
Celiac Disease 0.2 0.2
Chronic Fatigue Syndrome 0.2 0 0
Chronic Kidney Disease 0.6 0 0
Chronic Obstructive Pulmonary Disease (COPD) 0.2 0.2
Chronic Urticaria (Hives) 0.8 0.8
Coagulation / Micro clot triggering bacteria 0.8 0.8
Colorectal Cancer 0.8 0.5 0.6
Constipation 0.6 0.6
Coronary artery disease 1.1 0 0
COVID-19 0.8 0.3 1.67
Crohn's Disease 0.8 0 0
cystic fibrosis 0.8 0.8
d-lactic acidosis (one form of brain fog) 0.2 0.2
deep vein thrombosis 0.8 0.8
Depression 0.8 0.9 -0.13
Eczema 0.6 0.6
Endometriosis 0.8 0.2 3
Epilepsy 0.8 0.8
erectile dysfunction 0.6 0.6
Functional constipation / chronic idiopathic constipation 0.8 0.8
gallstone disease (gsd) 0.8 0.8
Generalized anxiety disorder 0.8 0.8
Heart Failure 0.8 0 0
High Histamine/low DAO 0.2 0.2
hypercholesterolemia (High Cholesterol) 0.2 0.2
hyperglycemia 0.8 0.8
hypertension (High Blood Pressure 0.6 0.6
Hypoxia 0.8 0.8
Inflammatory Bowel Disease 0.8 0.5 0.6
Insomnia 0.3 -0.3
Intelligence 0.2 0.2
Irritable Bowel Syndrome 0.8 0.8
ischemic stroke 0.2 0.9 -3.5
Liver Cirrhosis 1.1 0.2 4.5
Long COVID 0.9 0.3 2
Lung Cancer 0.6 0.6
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.6 0.6
Metabolic Syndrome 0.8 0.8
Mood Disorders 0.6 0.9 -0.5
Multiple Sclerosis 0.6 0 0
myasthenia gravis 0.6 0.6
Neuropathy (all types) 0.6 -0.6
neuropsychiatric disorders (PANDAS, PANS) 0.2 0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.8 0 0
Obesity 0.8 0.8
obsessive-compulsive disorder 0.8 0.3 1.67
Osteoarthritis 0.6 0.6
Osteoporosis 0.6 0.6
Parkinson's Disease 0.8 1.5 -0.88
Polycystic ovary syndrome 0.6 0.6
Psoriasis 0.2 0 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.6 0 0
scoliosis 0.2 0.2
Sjögren syndrome 0.6 0.3 1
Slow gastric motility / Gastroparesis 0.2 0.2
Small Intestinal Bacterial Overgrowth (SIBO) 0.2 0.2
Stress / posttraumatic stress disorder 0.2 0.2
Systemic Lupus Erythematosus 0.6 0.6 0
Type 1 Diabetes 0.6 0.6
Type 2 Diabetes 1.1 0.2 4.5
Ulcerative colitis 0.8 0.8
Unhealthy Ageing 0 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]